Azithromycin Dosing for Shigella Treatment in Children
For both the 5-year-old and 10-year-old, treat with azithromycin 10 mg/kg on day 1 (maximum 500 mg), followed by 5 mg/kg once daily on days 2-5 (maximum 250 mg per day). This is the preferred first-line antibiotic for shigellosis in children based on current guidelines 1, 2.
Dosing Specifics
Standard Regimen (Preferred)
- Day 1: 10 mg/kg as a single dose (max 500 mg)
- Days 2-5: 5 mg/kg once daily (max 250 mg/day)
- Total treatment duration: 5 days
This dosing applies to both age groups and is supported by FDA labeling 3, 4 and international guidelines 2.
Alternative Regimen
A 3-day course of 10 mg/kg/day can also be used, though the 5-day regimen is more commonly recommended for shigellosis specifically 1.
Key Clinical Considerations
Resistance patterns are critical: The 2017 IDSA guidelines identify azithromycin as first-line for shigellosis, but emphasize that ciprofloxacin resistance rates are increasing globally 1. Recent data shows concerning trends of decreased azithromycin susceptibility due to mph(A) gene carriage (up to 49% in some regions) 5, though azithromycin remains preferred over fluoroquinolones in children due to safety concerns.
When to consider alternatives:
- If local resistance patterns show high rates of azithromycin resistance (MIC >16 µg/mL), consider ceftriaxone (50-100 mg/kg/day IV/IM) or cefixime as oral alternatives 1, 2
- For severe illness with suspected sepsis in children <3 months: use ceftriaxone empirically 1
- Ciprofloxacin (15 mg/kg/dose twice daily, max 500 mg/dose) is an option but should be reserved given arthropathy concerns in children 2
Important Caveats
Treatment failures with azithromycin are emerging: Recent outbreak data demonstrates clinical failure rates with azithromycin when isolates have decreased susceptibility, even when technically "susceptible" by older breakpoints 6. If diarrhea persists ≥1 day after completing treatment, consider treatment failure and obtain repeat culture with susceptibility testing.
Empiric treatment indications are limited: Only treat empirically in children with:
- Bloody diarrhea (dysentery) with fever and abdominal pain
- Age <3 months with suspected bacterial etiology
- Immunocompromised status with severe illness 1
Otherwise, await culture confirmation before initiating antibiotics, as most gastroenteritis is viral and does not require treatment 7.
Tolerability: Azithromycin is generally well-tolerated in children with approximately 9-12% experiencing treatment-related adverse events, primarily mild-to-moderate gastrointestinal symptoms (diarrhea 3-6%, vomiting 2-5%) 8, 9. The suspension formulation is well-accepted by children.